| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.091 | 0.5 |